Capital Cell
Other
Active
Barcelona, Spain
42
1M
36
4.20
7
0.14
- Stages of investment
- Areas of investment
Summary
Capital Cell appeared to be the VC, which was created in 2014. The company was established in Europe in Spain. The main department of described VC is located in the Barcelona.
This organization was formed by Daniel Oliver. The overall number of key employees were 4.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Capital Cell, startups are often financed by EASME - EU Executive Agency for SMEs, Inveready Technology Investment Group, Calculus Capital. The meaningful sponsors for the fund in investment in the same round are Ship2B, Inveready Technology Investment Group, ENISA. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Ship2B, Inveready Technology Investment Group.
The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical Device, Life Science. Among the most popular portfolio startups of the fund, we may highlight Bionure, Ability Pharmaceuticals, Arcis Biotechnology. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain.
The common things for fund are deals in the range of 100 thousands - 1 million dollars. The average startup value when the investment from Capital Cell is 5-10 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 5 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2017.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 42
- Lead investments
- 7
- Rounds per year
- 4.20
- Follow on index
- 0.14
- Investments by industry
- Health Care (27)
- Biotechnology (24)
- Medical (20)
- Life Science (14)
- Medical Device (14) Show 21 more
- Investments by region
-
- Spain (35)
- United Kingdom (3)
- United States (3)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.38
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ducentis BioTherapeutics | 01 Aug 2017 | Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma | Seed | 1M | United Kingdom, England, West Oxfordshire |
| Exheus | 29 Nov 2022 | Health Care | Seed | 767K | Barcelona, Catalonia, Spain |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.